Osteogenic induction of hBMSCs by electrospun scaffolds with dexamethasone release functionality

Biomaterials

Volumn 31, Issue 22, 2010, Pages 5875-5885

  Martins, Albino ^a   Duarte, Ana Rita C ^a   Faria, Susana ^a   Marques, Alexandra P ^a   Reis, Rui L ^a   Neves, Nuno M ^a  

^a UNIVERSITY OF MINHO   (Portugal)

Author keywords

Bone tissue engineering; Drug release; Mesenchymal stem cells; Molecular biology; Polycaprolactone

Indexed keywords

ALKALINE PHOSPHATASE; AMORPHOUS STATE; BONE TISSUE ENGINEERING; CONCENTRATION OF; DEXAMETHASONES; DRUG RELEASE; DRUG RELEASE SYSTEM; ELECTROSPUNS; EXTRACELLULAR MATRICES; FIBROUS STRUCTURES; HUMAN BONE MARROW MESENCHYMAL STEM CELLS; IN-VITRO; MATRIX; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELLS; OSTEOGENIC; OSTEOGENIC ACTIVITY; OSTEOGENIC DIFFERENTIATION; POLYMERIC CARRIERS; RELEASE RATE; SINGLE-STEP PROCESS; STRUCTURAL SIMILARITY; SURFACE AREA; SUSTAINED RELEASE;

BIOCHEMISTRY; BONE; CELL CULTURE; DRUG PRODUCTS; MOLECULAR BIOLOGY; MOLECULAR STRUCTURE; NANOFIBERS; PHOSPHATASES; POLYCAPROLACTONE; POLYMERS; SCAFFOLDS; STEM CELLS;

TISSUE ENGINEERING;

ALKALINE PHOSPHATASE; BONE SIALOPROTEIN; DEXAMETHASONE; NANOFIBER; OSTEOCALCIN; OSTEOPONTIN; POLYCAPROLACTONE; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2;

ARTICLE; BONE DEVELOPMENT; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG RELEASE; ELECTROSPINNING; GENOTYPE; HUMAN; HUMAN CELL; IN VITRO STUDY; MESENCHYMAL STEM CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THERMAL ANALYSIS; TISSUE ENGINEERING;

BONE MARROW CELLS; CELL SURVIVAL; CELLS, CULTURED; DEXAMETHASONE; ELECTROCHEMICAL TECHNIQUES; GLUCOCORTICOIDS; HUMANS; MESENCHYMAL STEM CELLS; NANOFIBERS; OSTEOBLASTS; OSTEOGENESIS; POLYESTERS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 77953083188     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.04.010     Document Type: Article

References (45)

1. Goldberg M., Langer R., Jia X.Q. Nanostructured materials for applications in drug delivery and tissue engineering. J Biomater Sci Polym Ed 2007, 18(3):241-268.
2. Venugopal J., Low S., Choon A.T., Ramakrishna S. Interaction of cells and nanofiber scaffolds in tissue engineering. J Biomed Mater Res Part B 2008, 84(1):34-48.
3. Koo O.M., Rubinstein I., Onyuksel H. Role of nanotechnology in targeted drug delivery and imaging: a concise review. Nanomedicine 2005, 1(3):193-212.
4. Sill T.J., vonRecum H.A. Electrospinning: applications in drug delivery and tissue engineering. Biomaterials 2008, 29(13):1989-2006.
5. Xie J.B., Hsieh Y.L. Ultra-high surface fibrous membranes from electrospinning of natural proteins: casein and lipase enzyme. J Mater Sci 2003, 38(10):2125-2133.
6. Kenawy E.R., Bowlin G.L., Mansfield K., Layman J., Simpson D.G., Sanders E.H., et al. Release of tetracycline hydrochloride from electrospun poly(ethylene-co-vinylacetate), poly(lactic acid), and a blend. J Control Release 2002, 81(1-2):57-64.
7. Huang Z.M., Zhang Y.Z., Kotaki M., Ramakrishna S. A review on polymer nanofibers by electrospinning and their applications in nanocomposites. Compos Sci Technol 2003, 63(15):2223-2253.
8. Zhang Y.Z., Su B., Venugopal J., Ramakrishna S., Lim C.T. Biomimetic and bioactive nanofibrous scaffolds from electrospun composite nanofibers. Int J Nanomedicine 2007, 2(4):623-638.
9. Maretschek S., Greiner A., Kissel T. Electrospun biodegradable nanofiber nonwovens for controlled release of proteins. J Control Release 2008, 127(2):180-187.
10. Zeng J., Aigner A., Czubayko F., Kissel T., Wendorff J.H., Greiner A. Poly(vinyl alcohol) nanofibers by electrospinning as a protein delivery system and the retardation of enzyme release by additional polymer coatings. Biomacromolecules 2005, 6(3):1484-1488.
11. Townsend-Nicholson A., Jayasinghe S.N. Cell electrospinning: a unique biotechnique for encapsulating living organisms for generating active biological microthreads/scaffolds. Biomacromolecules 2006, 7(12):3364-3369.
12. Xu X., Chen X., Wang Z., Jing X. Ultrafine PEG-PLA fibers loaded with both paclitaxel and doxorubicin hydrochloride and their in vitro cytotoxicity. Eur J Pharm Biopharm 2009, 72(1):18-25.
13. Verreck G., Chun I., Peeters J., Rosenblatt J., Brewster M.E. Preparation and characterization of nanofibers containing amorphous drug dispersions generated by electrostatic spinning. Pharm Res 2003, 20(5):810-817.
14. Katti D.S., Robinson K.W., Ko F.K., Laurencin C.T. Bioresorbable nanofiber-based systems for wound healing and drug delivery: optimization of fabrication parameters. J Biomed Mater Res Part B 2004, 70B(2):286-296.
15. Dong B., Smith M.E., Wnek G.E. Encapsulation of multiple biological compounds within a single electrospun fiber. Small 2009, 5(13):1508-1512.
16. Sanders E.H., Kloefkorn R., Bowlin G.L., Simpson D.G., Wnek G.E. Two-phase electrospinning from a single electrified jet: microencapsulation of aqueous reservoirs in poly(ethylene-co-vinyl acetate) fibers. Macromolecules 2003, 36(11):3803-3805.
17. Chew S.Y., Wen J., Yim E.K., Leong K.W. Sustained release of proteins from electrospun biodegradable fibers. Biomacromolecules 2005, 6(4):2017-2024.
18. He C.L., Huang Z.M., Han X.J. Fabrication of drug-loaded electrospun aligned fibrous threads for suture applications. J Biomed Mater Res 2009, 89(1):80-95.
19. Jiang H., Hu Y., Li Y., Zhao P., Zhu K., Chen W. A facile technique to prepare biodegradable coaxial electrospun nanofibers for controlled release of bioactive agents. J Control Release 2005, 108(2-3):237-243.
20. Zhang Y.Z., Wang X., Feng Y., Li J., Lim C.T., Ramakrishna S. Coaxial electrospinning of (fluorescein isothiocyanate-conjugated bovine serum albumin)-encapsulated poly(epsilon-caprolactone) nanofibers for sustained release. Biomacromolecules 2006, 7(4):1049-1057.
21. Martins A., Araujo J.V., Reis R.L., Neves N.M. Electrospun nanostructured scaffolds for tissue engineering applications. Nanomedicine 2007, 2(6):929-942.
22. Tayalia P., Mooney D.J. Controlled growth factor delivery for tissue engineering. Adv Funct Mater 2009, 21:1-17.
23. Salgado A.J., Oliveira J.T., Pedro A.J., Reis R.L. Adult stem cells in bone and cartilage tissue engineering. Curr Stem Cell Res Ther 2006, 1(3):345-364.
24. Jaiswal N., Haynesworth S.E., Caplan A.I., Bruder S.P. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 1997, 64(2):295-312.
25. Li C., Vepari C., Jin H.J., Kim H.J., Kaplan D.L. Electrospun silk-BMP-2 scaffolds for bone tissue engineering. Biomaterials 2006, 27(16):3115-3124.
26. Nie H., Soh B.W., Fu Y.C., Wang C.H. Three-dimensional fibrous PLGA/HAp composite scaffold for BMP-2 delivery. Biotechnol Bioeng 2008, 99(1):223-234.
27. Bessa P.C., Casal M., Reis R.L. Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). J Tissue Eng Regen Med 2008, 2(2-3):81-96.
28. Martins A., Pinho E.D., Faria S., Pashkuleva I., Marques A.P., Reis R.L., et al. Surface modification of electrospun polycaprolactone nanofiber meshes by plasma treatment to enhance biological performance. Small 2009, 5(10):1195-1206.
29. Delorme B., Charbord P. Culture and characterization of human bone marrow mesenchymal stem cells. Methods Mol Med 2007, 140:67-81.
30. Venugopal J., Prabhakaran M.P., Low S., Choon A.T., Zhang Y.Z., Deepika G., et al. Nanotechnology for nanomedicine and delivery of drugs. Curr Pharm Des 2008, 14(22):2184-2200.
31. Balmayor E.R., Feichtinger G.A., Azevedo H.S., van Griensven M., Reis R.L. Starch-poly-ε-caprolactone microparticles reduce the needed amount of BMP-2. Clin Orthop Relat Res 2009, 267(12):3138-3148.
32. Balmayor E.R., Tuzlakoglu K., Azevedo H.S., Reis R.L. Preparation and characterization of starch-poly-epsilon-caprolactone microparticles incorporating bioactive agents for drug delivery and tissue engineering applications. Acta Biomater 2009, 5(4):1035-1045.
33. Balmayor E.R., Tuzlakoglu K., Marques A.P., Azevedo H.S., Reis R.L. A novel enzymatically-mediated drug delivery carrier for bone tissue engineering applications: combining biodegradable starch-based microparticles and differentiation agents. J Mater Sci Mater Med 2008, 19(4):1617-1623.
34. Oliveira J.M., Sousa R.A., Kotobuki N., Tadokoro M., Hirose M., Mano J.F., et al. The osteogenic differentiation of rat bone marrow stromal cells cultured with dexamethasone-loaded carboxymethylchitosan/poly(amidoamine) dendrimer nanoparticles. Biomaterials 2009, 30(5):804-813.
35. Oliveira J.M., Kotobuki N., Marques A.P., Pirraco R.P., Benesch J., Hirose M., et al. Surface engineered carboxymethylchitosan/poly(amidoamine) dendrimer nanoparticles for intracellular targeting. Adv Funct Mater 2008, 18(12):1840-1853.
36. Duarte A.R.C., Mano J.F., Reis R.L. Dexamethasone-loaded scaffolds prepared by supercritical-assisted phase inversion. Acta Biomater 2009, 5(6):2054-2062.
37. Eroglu H., Kas H.S., Oner L., Turkoglu O.F., Akalan N., Sargon M.F., et al. The in-vitro and in-vivo characterization of PLGA:L-PLA microspheres containing dexamethasone sodium phosphate. J Microencapsul 2001, 18(5):603-612.
38. Yoon J.J., Kim J.H., Park T.G. Dexamethasone-releasing biodegradable polymer scaffolds fabricated by a gas-foaming/salt-leaching method. Biomaterials 2003, 24(13):2323-2329.
39. Silva G.A., Costa F.J., Neves N.M., Coutinho O.P., Dias A.C., Reis R.L. Entrapment ability and release profile of corticosteroids from starch-based microparticles. J Biomed Mater Res 2005, 73(2):234-243.
40. Habibovic P., de Groot K. Osteoinductive biomaterials-properties and relevance in bone repair. J Tissue Eng Regen Med 2007, 1(1):25-32.
41. Abidian M.R., Martin D.C. Multifunctional nanobiomaterials for neural interfaces. Adv Funct Mater 2009, 19(4):573-585.
42. Beresford J.N., Joyner C.J., Devlin C., Triffitt J.T. The effects of dexamethasone and 1,25-dihydroxyvitamin D3 on osteogenic differentiation of human marrow stromal cells in vitro. Arch Oral Biol 1994, 39(11):941-947.
43. zur Nieden N.I., Kempka G., Ahr H.J. In vitro differentiation of embryonic stem cells into mineralized osteoblasts. Differentiation 2003, 71(1):18-27.
44. Ryoo H.M., Lee M.H., Kim Y.J. Critical molecular switches involved in BMP-2-induced osteogenic differentiation of mesenchymal cells. Gene 2006, 366(1):51-57.
45. Satija N.K., Gurudutta G.U., Sharma S., Afrin F., Gupta P., Verma Y.K., et al. Mesenchymal stem cells: molecular targets for tissue engineering. Stem Cells Dev 2007, 16(1):7-23.